Literature DB >> 11451187

Ulcerative colitis associated with interferon treatment for chronic hepatitis C.

C Mavrogiannis, I S Papanikolaou, I S Elefsiniotis, D I Psilopoulos, A Karameris, G Karvountzis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11451187     DOI： 10.1016/s0168-8278(01)00022-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  15 in total

1.  Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.

Authors:  R Sprenger; M Sagmeister; F Offner
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.

Authors:  T Watanabe; M Inoue; K Harada; N Homma; M Uchida; N Ogata; R Funada; K Hasegawa; K Soga; K Shibasaki
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

3.  Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yvette Leung; Stefan J Urbanski; Lynn Schindel; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

4.  Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.

Authors:  M Higashiyama; R Hokari; C Kurihara; T Ueda; M Nakamura; S Komoto; Y Okada; C Watanabe; A Kawaguchi; S Nagao; S Miura
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

5.  Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.

Authors:  Sukumar Saha; Xuefang Jing; Shin Yong Park; Shiyong Wang; Xinna Li; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2010-08-19       Impact factor: 21.023

6.  IFNαR signaling in effector but not regulatory T cells is required for immune dysregulation during type I IFN-dependent inflammatory disease.

Authors:  Shivani Srivastava; Lisa K Koch; Daniel J Campbell
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

7.  Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.

Authors:  Farooq Z Rahman; Andrew M Smith; Bu'Hussain Hayee; Daniel J B Marks; Stuart L Bloom; Anthony W Segal
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

8.  Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

Authors:  Alina M Allen; W Ray Kim; Joseph Larson; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

Review 9.  Hepatitis C virus and inflammatory bowel disease.

Authors:  Todd L Horn; Joel Reynolds; Willem de Villiers; Luis R Peña
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

Review 10.  Type I interferons for induction of remission in ulcerative colitis.

Authors:  Yongjun Wang; John K MacDonald; Eric I Benchimol; Anne Marie Griffiths; A Hillary Steinhart; Remo Panaccione; Cynthia H Seow
Journal:  Cochrane Database Syst Rev       Date:  2015-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.